PT2111868E - Utilização de albumina humana terapêutica na preparação de um medicamento para o tratamento de doentes sofrendo de distúrbios cognitivos - Google Patents
Utilização de albumina humana terapêutica na preparação de um medicamento para o tratamento de doentes sofrendo de distúrbios cognitivosInfo
- Publication number
- PT2111868E PT2111868E PT83803015T PT08380301T PT2111868E PT 2111868 E PT2111868 E PT 2111868E PT 83803015 T PT83803015 T PT 83803015T PT 08380301 T PT08380301 T PT 08380301T PT 2111868 E PT2111868 E PT 2111868E
- Authority
- PT
- Portugal
- Prior art keywords
- drug
- preparation
- treatment
- patients suffering
- cognitive disorders
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 4
- 102000008100 Human Serum Albumin Human genes 0.000 title abstract 3
- 108091006905 Human Serum Albumin Proteins 0.000 title abstract 3
- 208000010877 cognitive disease Diseases 0.000 title abstract 3
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200702831A ES2332846B1 (es) | 2007-10-26 | 2007-10-26 | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2111868E true PT2111868E (pt) | 2013-10-17 |
Family
ID=40583637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT83803015T PT2111868E (pt) | 2007-10-26 | 2008-10-22 | Utilização de albumina humana terapêutica na preparação de um medicamento para o tratamento de doentes sofrendo de distúrbios cognitivos |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7851446B2 (pt) |
| EP (1) | EP2111868B1 (pt) |
| JP (1) | JP5437619B2 (pt) |
| CN (1) | CN101417123B (pt) |
| AR (1) | AR068901A1 (pt) |
| AU (1) | AU2008233025B8 (pt) |
| BR (1) | BRPI0804623B8 (pt) |
| CA (1) | CA2641830C (pt) |
| CL (1) | CL2008003133A1 (pt) |
| ES (2) | ES2332846B1 (pt) |
| MX (1) | MX2008013635A (pt) |
| NZ (1) | NZ572131A (pt) |
| PL (1) | PL2111868T3 (pt) |
| PT (1) | PT2111868E (pt) |
| RU (1) | RU2414925C2 (pt) |
| UY (1) | UY31418A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10112000B2 (en) | 2010-07-08 | 2018-10-30 | Asahi Kasei Medical Co., Ltd. | Method for reducing amyloid beta concentration in blood |
| US10525107B2 (en) | 2016-08-18 | 2020-01-07 | Alkahest, Inc. | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| WO2018034712A1 (en) * | 2016-08-18 | 2018-02-22 | Alkahest, Inc. | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| WO2018200560A1 (en) * | 2017-04-26 | 2018-11-01 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| CA3105956A1 (en) * | 2018-07-20 | 2020-01-23 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| EP3643319A1 (en) * | 2018-10-25 | 2020-04-29 | Grifols Worldwide Operations Limited | Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages |
| CN119345230A (zh) | 2018-10-26 | 2025-01-24 | 万能溶剂有限公司 | 血浆和血浆组分用于改善疼痛的用途 |
| CN116406374A (zh) | 2020-10-30 | 2023-07-07 | 深圳普罗吉医药科技有限公司 | 人血清白蛋白在治疗疾病中的应用 |
| MX2023011872A (es) * | 2021-04-30 | 2023-10-17 | Grifols Worldwide Operations Ltd | Uso de recambio plasmatico terapeutico y recambio plasmatico de bajo volumen para el tratamiento de un deterioro cognitivo. |
| WO2025230830A1 (en) | 2024-04-29 | 2025-11-06 | Alkahest, Inc. | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3612137A1 (de) * | 1986-04-10 | 1987-10-15 | Biotest Pharma Gmbh | Steriles plasmaaustauschmittel |
| US5112298A (en) | 1990-06-25 | 1992-05-12 | Baxter International Inc. | Apheresis method and device |
| US5178603A (en) | 1990-07-24 | 1993-01-12 | Baxter International, Inc. | Blood extraction and reinfusion flow control system and method |
| US6627151B1 (en) * | 1997-06-13 | 2003-09-30 | Helmut Borberg | Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion |
| WO2001090758A2 (en) | 2000-05-23 | 2001-11-29 | The University Of Southern California | Diagnosis of alzheimer's disease ldl receptor protein-1 |
| EP1370240A4 (en) * | 2001-03-02 | 2004-09-22 | Neuron Therapeutics Inc | NEUROPROTECTOR FORMULATIONS AND METHOD |
| US20050227941A1 (en) | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
| KR101122782B1 (ko) | 2002-10-04 | 2012-04-12 | 프라나 바이오테크놀로지 리미티드 | 신경 활성 화합물 |
| WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
| KR20050103292A (ko) | 2003-02-13 | 2005-10-28 | 옥타파르마 아게 | 알부민 용액 및 이의 제조 방법 |
| AU2004311577A1 (en) | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
| AT413336B (de) * | 2003-09-12 | 2006-02-15 | Mattner Frank Dr | Apherese-vorrichtung |
| US20050182044A1 (en) | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| RU2261702C1 (ru) * | 2004-09-23 | 2005-10-10 | Смирнов Алексей Владимирович | Способ лечения гипергомоцистеинемии у больных с хронической почечной недостаточностью, получающих лечение гемодиализом или гемофильтрацией |
| RU2281090C2 (ru) * | 2004-09-23 | 2006-08-10 | Алексей Владимирович Смирнов | Способ лечения больных хронической почечной недостаточностью |
| US7436304B1 (en) | 2005-07-19 | 2008-10-14 | Visible Assets, Inc | Evidence tracking |
-
2007
- 2007-10-26 ES ES200702831A patent/ES2332846B1/es not_active Expired - Fee Related
-
2008
- 2008-10-17 AR ARP080104523A patent/AR068901A1/es unknown
- 2008-10-17 RU RU2008141076/15A patent/RU2414925C2/ru active
- 2008-10-17 NZ NZ572131A patent/NZ572131A/en unknown
- 2008-10-22 ES ES08380301T patent/ES2428698T3/es active Active
- 2008-10-22 PL PL08380301T patent/PL2111868T3/pl unknown
- 2008-10-22 PT PT83803015T patent/PT2111868E/pt unknown
- 2008-10-22 EP EP08380301.5A patent/EP2111868B1/en active Active
- 2008-10-23 MX MX2008013635A patent/MX2008013635A/es active IP Right Grant
- 2008-10-23 CL CL2008003133A patent/CL2008003133A1/es unknown
- 2008-10-23 UY UY31418A patent/UY31418A1/es not_active Application Discontinuation
- 2008-10-23 BR BRPI0804623A patent/BRPI0804623B8/pt active IP Right Grant
- 2008-10-23 CN CN2008101705786A patent/CN101417123B/zh active Active
- 2008-10-24 AU AU2008233025A patent/AU2008233025B8/en active Active
- 2008-10-24 CA CA2641830A patent/CA2641830C/en active Active
- 2008-10-24 US US12/257,814 patent/US7851446B2/en active Active
- 2008-10-24 JP JP2008274076A patent/JP5437619B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2414925C2 (ru) | 2011-03-27 |
| CA2641830A1 (en) | 2009-04-26 |
| CN101417123A (zh) | 2009-04-29 |
| PL2111868T3 (pl) | 2014-01-31 |
| AU2008233025A1 (en) | 2009-05-14 |
| AU2008233025B2 (en) | 2013-06-27 |
| CN101417123B (zh) | 2012-06-27 |
| JP5437619B2 (ja) | 2014-03-12 |
| JP2009108059A (ja) | 2009-05-21 |
| CA2641830C (en) | 2013-07-16 |
| US7851446B2 (en) | 2010-12-14 |
| BRPI0804623A2 (pt) | 2009-06-30 |
| AU2008233025B8 (en) | 2013-07-25 |
| MX2008013635A (es) | 2009-05-11 |
| CL2008003133A1 (es) | 2009-08-07 |
| ES2332846A1 (es) | 2010-02-12 |
| UY31418A1 (es) | 2009-05-29 |
| RU2008141076A (ru) | 2010-04-27 |
| AR068901A1 (es) | 2009-12-16 |
| BRPI0804623B8 (pt) | 2021-05-25 |
| ES2428698T3 (es) | 2013-11-08 |
| HK1126689A1 (en) | 2009-09-11 |
| US20090111740A1 (en) | 2009-04-30 |
| ES2332846B1 (es) | 2010-07-08 |
| NZ572131A (en) | 2010-06-25 |
| EP2111868A1 (en) | 2009-10-28 |
| BRPI0804623B1 (pt) | 2020-02-11 |
| EP2111868B1 (en) | 2013-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2111868E (pt) | Utilização de albumina humana terapêutica na preparação de um medicamento para o tratamento de doentes sofrendo de distúrbios cognitivos | |
| JP2022009125A5 (pt) | ||
| WO2008022189A3 (en) | Administration of high potency platinum compound formulations by inhalation | |
| JP2006501240A5 (pt) | ||
| MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
| WO2008066856A3 (en) | Patient specific ankle-foot orthotic device | |
| NZ613291A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| PT2210605T (pt) | Formas de dosagem única diária de tróspio | |
| HK1202776A1 (en) | Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy | |
| WO2008067991A3 (en) | Skin-friendly drug complexes for transdermal administration | |
| EP2216024A3 (en) | Use of Ranolazine for the treatment of cardiovascular diseases | |
| WO2006129304A3 (en) | Pulsating inhaler and a method of treating upper respiratory disorders | |
| MY135838A (en) | Methods for the treatment of mental disorders | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| EP1728076A4 (en) | SYSTEM AND METHOD FOR PROVIDING OPTIMUM CONCENTRATIONS FOR MEDICAMENT INFUSIONS | |
| WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
| EP2545929A4 (en) | Means for the alleviation or cure of chronic prostatitis, interstitial cystitis or bladder-weaning disorders | |
| KR101874951B1 (ko) | 립실 테이프 | |
| UA81573C2 (en) | Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients | |
| WO2001089537A3 (en) | Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders | |
| DE602007014193D1 (de) | Behandlung psychiatrischer patienten mit schlafstörungen und/oder übermässiger tagesschläfrigkeit mit paliperidon | |
| RU2006101061A (ru) | Азенапин для лечения шизофрении у пациентов с избыточной массой тела или предрасположенностью к избыточной массе тела | |
| CN201295460Y (zh) | 医用供药口罩 | |
| WO2008079818A3 (en) | Intravenous administration of water soluble analgesic formulations | |
| NZ599227A (en) | Therapeutic agent for chronic pain |